Researchers explore what happens when heart cells fail

by Jasmine Sola
Researchers explore what happens when heart cells fail
Left and right ventricles of a normal mouse heart (left) and one with a mutation in the cardiac isoform of myosin binding protein C.

Through a grant from the United States-Israel Binational Science Foundation, Biomedical Engineering Associate Professor Naomi Chesler will embark upon a new collaborative research project to better understand heart function and failure. "This is unique opportunity to combine theoretical and the experimental approaches and to develop a collaboration with an Israeli investigator," Chesler says.

Chesler will work with Richard Moss, the UW-Madison School of Medicine and Public Health associate dean for basic research, biotechnology and graduate studies; and with Amir Landesberg, dean of biomedical engineering at Technion-Israel Institute of Technology.

Landesberg has developed a novel model of at the cellular level, while Chesler's team has been improving methods to study heart function at the whole organ level in small animal models. Moss not only has expertise in experimental measurement of heart function at the , but also genetically engineered that have a mutation in one protein in the cells of the heart that generate force that leads to dilation and dysfunction.

These mice will allow Chesler and Moss to test the theoretical model developed by Landesberg.

While Moss will oversee the group that breeds the mice, Chesler will oversee experimental treatment of the mice.

Chesler also hopes to learn more about the mathematical model of heart cell function, which is Landesberg's expertise. Models, such as the one used by Landesberg, help bridge the gap in understanding functions in mice and functions in humans.

"We are hoping to understand what happens in people with heart disease. If we better understand heart cell function and dysfunction, we might be able to develop better metrics of early dysfunction," Chesler says. "If we find early dysfunction in people, then we might be able to treat them earlier and actually prevent heart failure."

add to favorites email to friend print save as pdf

Related Stories

Research may yield improved treatment for diseased lungs

May 24, 2007

A multi-institutional team of engineers, scientists and clinicians from the University of Wisconsin-Madison will study large-artery biomechanics that could play a role in heart failure in patients with pulmonary arterial ...

Healing the heart with fat

Jul 21, 2014

Too much dietary fat is bad for the heart, but the right kind of fat keeps the heart healthy, according to a paper published in The Journal of Experimental Medicine.

Misplaced protein causes heart failure

Mar 06, 2014

Colchicine, a drug that's used to treat gout, has the beneficial side effect of lowering the risk of heart attack in patients taking it. Conversely, taxol, a drug for treating cancer, has the opposite effect; ...

Impaired activity of the protein MTOR a strain on the heart

Jul 19, 2010

A team of researchers, led by Gianluigi Condorelli, at the University of California San Diego, La Jolla, has generated data in mice that suggest that drugs that inhibit the protein MTOR, which are used to treat several forms ...

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

Nov 20, 2014

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.